Postoperative Opioid Use in Staged Gender-Affirming Facial Surgery

Abstract

Get full access to this article

View all access options for this article.

References

Salesky

, Zebolsky

, Benjamin

, et al. Gender-affirming facial surgery: experiences and outcomes at an academic center. Facial Plast Surg Aesthet Med. 2022; 24(1):54–59.

Benotsch

, Zimmerman

, Cathers

, et al. Non-medical use of prescription drugs, polysubstance use, and mental health in transgender adults. Drug Alcohol Depend. 2013; 132(1–2):391–394.

Mcpherson

. Calculating Conversations in Opioid Conversions. n.d. Available from: https://www.fda.gov/media/150396/download [Last accessed: October 12, 2023].

Olds

, Spataro

, Li

, et al. Assessment of persistent and prolonged postoperative opioid use among patients undergoing plastic and reconstructive surgery. JAMA Facial Plast Surg. 2019; 21(4):286–291.

Chou

, Block-Wheeler

, Kshirsagar

, et al. Postoperative pain and opioid use after facial feminization surgery. Facial Plast Surg. 2022; 38(3):240–244.

Bedar

, Dejam

, Caprini

, et al. An enhanced recovery after surgery protocol for facial feminization surgery reduces perioperative opioid usage, pain, and hospital stay. J Plast Reconstr Aesthet Surg. 2023; 85:393–400.